全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
华西医学  2011 

IgA肾病肾血管病变危险因素的非条件logistic回归分析

, PP. 1121-1124

Keywords: IgA肾病,肾血管病变,多因素非条件logistic回归模型,危险因素

Full-Text   Cite this paper   Add to My Lib

Abstract:

【】 目的 探讨IgA肾病肾血管病变的危险因素。 方法 回顾性分析2000年1月-2009年6月间经肾活检确诊的175例IgA肾病患者资料,其中有肾血管病变者93例,无肾血管病变者82例,进行对照研究。采用多因素非条件logistic回归模型分析影响IgA肾病肾血管病变的危险因素。 结果 高血压OR=11.593,P=0.001,95%CI(2.800,47.991)、24h尿蛋白定量OR=1.754,P=0.001,95%CI(1.270,2.424)、血肌酐OR=1.005,P=0.001,95%CI(1.002,1.008)、肾小球硬化OR=8.341,P=0.000,95%CI(2.716,25.610)、肾间质纤维化OR=4.880,P=0.014,95%CI(1.385,17.199)对IgA肾病肾血管病变的影响有统计学意义。 结论 高血压、24h尿蛋白定量、血肌酐、肾小球硬化和肾间质纤维化可能是影响IgA肾病肾血管病变的独立危险因素。积极控制以上危险因素对延缓IgA肾病病变的进展具有重要意义。【Abstract】 Objective ToexploretheriskfactorsforrenalvascularlesionsinpatientswithimmunoglobulinA(IgA)nephropathy. Methods Weretrospectivelyanalyzedtheclinicaldataof175IgAnephropathypatientsdiagnosedthroughrenalbiopsyfromJanuary2000toJune2009.Amongthem,therewere98casesofrenalvascularlesionsand82caseswithoutrenalvascularlesion.Controlledstudybetweenthetwogroupsofpatientswerecarriedout.AmultivariateunconditionallogisticregressionmodelwasemployedtoanalyzetheriskfactorsforrenalvascularlesionsinIgAnephropathypatients. Results ThefollowingfactorshadsignificantcorrelationswithrenalvascularlesionsinIgAnephropathypatientshypertensionOR=11.593,P=0.001,95%CI(2.800,47.991),24-hoururineproteinlevelOR=1.754,P=0.001,95%CI(1.270,2.424),serumcreatinineOR=1.005,P=0.001,95%CI(1.002,1.008),glomerulosclerosisOR=8.341,P=0.000,95%CI(2.716,25.610),andrenalinterstitialfibrosisOR=4.880,P=0.014,95%CI(1.385,17.199). Conclusion Hypertension,24-hoururineprotein,serumcreatinine,glomerulosclerosisandrenalinterstitialfibrosiswereriskfactorsforrenalvascularlesionsinIgAnephropathypatients.Itwillbeverysignificanttoactivelycontrolalltheaboveriskfactorstopreventoccurrenceofrenalvascularlesions.

References

[1]   Donadio JV. Recent advances in IgA nephropathy[J]. Kidney Int, 2009, 76(10): 1015-1016.
[2]   宋立群, 刘道银, 宋业旭. IgA肾病中医药研究进展[J]. 光明中医, 2010, 25(3): 536-537.
[3]   Walsh M, Sar A, Lee D, et al. Histopathologic features aid in predicting risk for progression of IgA nephropathy[J]. Clin J Am Soc Nephrol, 2010, 5(3): 425-430.
[4]   Tan Y, Zhang JJ, Liu G, et al. The level of urinary secretory immunoglobulin A(sIgA) of patients with IgA nephropathy is elevated and associated with pathological phenotypes[J]. Clin Exp Immunol, 2009, 156(1): 111-116.
[5]   Working Group of the International IgA Nephropathy Network and the Renal Pathology Society. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification[J]. Kidney Int, 2009, 76(6): 534-545.
[6]   张欣, 吴慧娟, 万鹏, 等. 肾血管病变在 IgA肾病病理中的意义[J]. 中国医学创新, 2009, 6(8): 9-11.
[7]   Tang SC, Tang AW, Wong SS, et al. Long-term study of mycophenolate mofetil treatment in IgA nephropathy[J]. Kidney Int, 2010, 77(6): 543-549.
[8]   黎磊石, 刘志宏. 中国肾脏病学[M]. 3版. 北京: 人民军医出版社, 2008: 447.
[9]   Goto M, Wakai K, Kawamura T, et al. A scoring system to predict renal outcome in IgA nephropathy: a nationwide10-year prospective cohort study[J]. Nephrol Dial Transplant, 2009, 24(10): 3068-3074.
[10]   Reich HN, Troyanov S, Scholey JW, et al.Remission of proteinuria improves prognosis in IgA nephropathy[J]. J Am Soc Nephrol, 2007, 18(12): 3177-3183.
[11]   施珍, 潘殊方, 谷定英, 等. 121例原发性IgA肾病的临床与病理及相关性分析[J]. 中国中西医结合肾病杂志, 2010, 11(5): 434-436.
[12]   路杰, 许勇芝, 黄志清, 等. IgA肾病308例临床与病理分析[J]. 中华全科医学, 2011, 9(4): 525-527.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133